Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
Clinical trial NCT06150924 · COMPLETED
Trial details
- NCT number
- NCT06150924
- Sponsor
- Mineralys Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-14
- Primary completion
- 2025-02-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.